Her-1, her-3 and igf-1r compositions and uses thereof

Abstract

Provided herein are HER-3, HER-1 and IGF-1R B cell epitopes, peptide mimics, chimeric peptides and multivalent peptides. In some embodiments, the chimeric peptides include one or more HER-3, HER-1 and/or IGF-1R B cell epitopes, a linker, and a T helper cell (Th cell) epitope. Pharmaceutical compositions are also provided that contain one or more HER-3, HER-1 and/or IGF-1R chimeric peptides, and optionally, one or more HER-2 chimeric peptides and/or VEGF peptides. Also included herein are methods of treating a cancer using the HER-3, HER-1 and IGF-1R B cell epitopes, chimeric peptides and multivalent peptides.

1 - 4 . (canceled) 
     
     
         5 . A HER-1 chimeric peptide for stimulating an immune response to a HER-1 protein comprising one or more HER-1 B cell epitopes, a T helper (Th) epitope, and a linker joining the HER-1 B cell epitope to the Th epitope, wherein:
 a. the one or more HER-1 B cell epitopes consist of a sequence selected from the group consisting of: SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3;   b. the Th epitope comprises a sequence selected from the group consisting of: SEQ ID NO: 12, SEQ ID NO:13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16 SEQ ID NO: 17, SEQ ID NO: 18, and SEQ ID NO:19; and   c. the linker comprises a sequence that is from 1 to 15 amino acids in length.   
     
     
         6 . The chimeric peptide of  claim 5 , wherein the Th epitope comprises SEQ ID NO:12. 
     
     
         7 . The chimeric peptide of  claim 5 , wherein the linker comprises SEQ ID NO:20. 
     
     
         8 . The chimeric peptide of  claim 6 , wherein the HER-1 B cell epitope consists of SEQ ID NO:3. 
     
     
         9 . An IGF-1R chimeric peptide for stimulating an immune response to an IGF-1R protein comprising one or more IGF-1R B cell epitopes, a T helper (Th) epitope, and a linker joining the IGF-1R B cell epitope to the Th epitope, wherein
 a. the one or more IGF-1R B cell epitopes consist of a sequence selected from the group consisting of SEQ ID NO:8, SEQ ID NO:9, SEQ ID NO:10, and SEQ ID NO:11;   b. the Th epitope comprises a sequence selected from the group consisting of: SEQ ID NO: 12, SEQ ID NO:13, SEQ ID NO: 14, SEQ ID NO: 15, SEQ ID NO: 16 SEQ ID NO: 17, SEQ ID NO: 18, and SEQ ID NO:19; and   c. the linker comprises a sequence that is from 1 to 15 amino acids in length.   
     
     
         10 . The chimeric peptide of  claim 9 , wherein the Th epitope comprises SEQ ID NO:12. 
     
     
         11 . The chimeric peptide of  claim 9 , wherein the linker comprises SEQ ID NO:20. 
     
     
         12 . The chimeric peptide of  claim 10  or  11 , wherein the IGF-1R B cell epitope consists of SEQ ID NO:10 or SEQ ID NO:11. 
     
     
         13 - 21 . (canceled)